Welcome to our dedicated page for PONY news (Ticker: PONY), a resource for investors and traders seeking the latest updates and insights on PONY stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PONY's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PONY's position in the market.
Pony AI has announced the pricing of its initial public offering of 20,000,000 American depositary shares (ADSs) at US$13 per ADS. The ADSs will trade on the Nasdaq Global Select Market under the symbol PONY starting November 27, 2024. The company has granted underwriters a 30-day option to purchase up to 3,000,000 additional ADSs. Concurrent with the IPO, strategic investors have committed to purchase approximately US$153.4 million worth of Class A ordinary shares in private placements. The total gross proceeds are expected to reach US$413.4 million, or US$452.4 million if underwriters exercise their full option.
